Lipoprotein-Associated Phospholipase A2Protein Expression in the Natural Progression of Human Coronary Atherosclerosis-Reference-Cited by-同舟云学术

Lipoprotein-Associated Phospholipase A2Protein Expression in the Natural Progression of Human Coronary Atherosclerosis

Published:2006-11 Issue:11 Volume:26 Page:2523-2529
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Kolodgie Frank D.¹,Burke Allen P.¹,Skorija Kristi S.¹,Ladich Elena¹,Kutys Robert¹,Makuria Addisalem Taye¹,Virmani Renu¹

Affiliation:

1. From CVPath Institute, Inc (F.D.K., A.P.B., K.S.S., E.L., R.K., R.V.), Gaithersburg, Md; and the Department of Pathology (A.T.M.), Georgetown University, Washington, DC.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Pathology of the Vulnerable Plaque

2. Inflammation, Atherosclerosis, and Coronary Artery Disease

3. Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

4. Lipoprotein-Associated Phospholipase A 2 , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Stroke Recurrence Risk by Using a Lipoprotein-Associated Phospholipase A2 and Platelet Count-Based Nomogram;Molecular Neurobiology;2024-08-23

2. Association of High‐Sensitivity C‐Reactive Protein and Lipoprotein‐Associated Phospholipase A2 with Metabolically Unhealthy Phenotype: A Cross Sectional Study;Journal of Inflammation Research;2024-01

3. Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2;Chinese Journal of Integrative Medicine;2023-12-07

4. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism;Nature Communications;2023-09-15

5. Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism;2023-04-09